| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
Aadi Bioscience, Inc.
13D/A
WHWK · 00032Q104
|
4.9% |
3/6/2025
Event 3/4/2025
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.